Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks end four-day winning run as UK's FTSE drags

Thu, 13th Aug 2020 09:39

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* FTSE 100 leads declines on ex-dividend trading

* Cyclical sectors hand back some of this week's gains

* Thyssenkrupp slides on flagging losses in steel unit

* TUI sinks to 1 bln euro loss in Q3
(Updates to market close)

By Sruthi Shankar and Sagarika Jaisinghani

Aug 13 (Reuters) - European stocks broke a four-day winning
streak on Thursday as ex-dividend trading and a stronger pound
hit the UK's blue-chip companies, while investors sold off banks
and energy stocks that have outperformed this week.

The pan-European STOXX 600 closed 0.6% lower, with
London's FTSE 100 sliding 1.5% as a jump in the pound
hurt exporters on the index, while heavyweights like AstraZeneca
, BP, and GlaxoSmithKline traded without
entitlement to a dividend payout, hitting their shares.

Reversing a recent trend, investors favoured pockets of
markets that have remained resilient in the wake of the
coronavirus crisis such as the technology sector. On Wall
Street, Apple was set to record $2 trillion in market
capitalisation.

That left some of the cyclical sectors that are more exposed
to an economic downturn, such as banks, oil & gas
, miners and automakers, falling between
0.8% and 1.9%.

Geir Lode, head of global equities international at
Federated Hermes, noted that it is difficult to gauge whether a
rally in these cheaper stocks will be sustained.

"It reflects the uncertainty that still pervades the world
as we continue to negotiate our way back to normality as well as
increasing U.S.-China tensions," Lode wrote in a note.

After a U.S. move to ban two popular Chinese apps last week,
investors were nervous about upcoming talks between Beijing and
Washington officials over a trade deal agreed earlier this year.

Meanwhile, U.S. Democrats and Republicans remain deadlocked
after weeks of wrangling over a fifth coronavirus aid bill to
support a struggling economy.

Trillions of dollars in stimulus and a stellar rally in
technology stocks have helped the U.S. S&P 500 index
reach striking distance of a record high. The European blue-chip
index is still about 15% below its February peak, but
the pace of recovery for both from a market crash in March has
been similar.

Weak earnings also dented the mood, with struggling
conglomerate Thyssenkrupp plunging 16.3% after it said
its steel unit would rack up 1 billion euros ($1.2 billion) in
operating losses this year, raising pressure to fix or sell the
division.

TUI, the world's largest tourism company, fell 6.2%
as it sank to a 1.1 billion euro ($1.30 billion) loss in the
third quarter due to the COVID-19 pandemic.

Danish brewer Carlsberg slid 5.8% on a warning
that lockdowns will impact sales in the second half of the year
in its key markets of China and Western Europe.

(Reporting by Sruthi Shankar in Bengaluru; Additional reporting
by Sagarika Jaisinghani; Editing by Arun Koyyur, Bernard Orr and
Giles Elgood)

More News
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.